跳至主要内容
临床试验/CTRI/2020/01/022912
CTRI/2020/01/022912招募中2 期

A randomized controlled clinical study to evaluate the role of Dadimadi Avaleha as palliative care of Sickle cell anaemia in children

Department of Kaumarbhritya0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Age between 3yrs to 16 yrs irrespective of gender.
  • 2 Hb >6.5% and <11.5%.
  • 3 Pre diagnosed cases will be taken.
  • 4 Patients with positive sickling test.
  • 5 Patients with sign and symptoms of Sickle cell Anaemia like pallor, fatique, pain, loss of appetite etc.

排除标准

  • 1 Age less than 3yrs and greater than 16 yrs.
  • 2 Hb <6.5% and >11.5%.
  • 3 SCA associated with other disease like Diabetes Mellitus, Hypertension, Thalassemia.

研究者

发起方
Department of Kaumarbhritya

相似试验